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Abstract
The lipopolysaccharide (LPS) is considered the major virulent factor in Brucella spp. Several genes have been identified
involved in the synthesis of the three LPS components: lipid A, core and O-PS. Usually, Brucella strains devoid of O-PS (rough
mutants) are less virulent than the wild type and do not induce undesirable interfering antibodies. Such of them proved to
be protective against brucellosis in mice. Because of these favorable features, rough strains have been considered potential
brucellosis vaccines. In this study, we evaluated the antigenic, immunologic and genetic characteristics of rough strains
B.abortus RB51, B.melitensis B115 and B.melitensis B18. RB51 derived from B.abortus 2308 virulent strain and B115 is a
natural rough strain in which the O-PS is present in the cytoplasm. B18 is a rough rifampin-resistan mutant isolated in our
laboratory. The surface antigenicity of RB51, B115 and B18 was evaluated by testing their ability to bind antibodies induced
by rough or smooth Brucella strains. The antibody response induced by each strain was evaluated in rabbits. Twenty-one
genes, involved in the LPS-synthesis, were sequenced and compared with the B.melitensis 16M strain. The results indicated
that RB51, B115 and B18 have differences in antigenicity, immunologic and genetic properties. Particularly, in B115 a
nonsense mutation was detected in wzm gene, which could explain the intracellular localization of O-PS in this
strain. Complementation studies to evaluate the precise role of each mutation in affecting Brucella morphology and its
virulence, could provide useful information for the assessment of new, attenuated vaccines for brucellosis.
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Introduction
In Brucella spp., as in many other gram-negative bacteria, the
smooth lipopolysaccharide (S-LPS) is an important component of
the outer membrane, strongly involved in pathogenesis mecha-
nisms. Its precise role as a virulence factor is not yet clear. It has
been suggested, however, that the LPS molecule may play a key
role in the invasion and intracellular multiplication of Brucella spp.
as well as in protecting the cell against complement-mediated lysis.
Moreover, the LPS is the immunodominant antigen to which the
majority of antibodies resulting from either infection or vaccina-
tion are directed [1–4].
The S-LPS molecule has three sections: the lipid A, the core
oligosaccharide and the distal O-polysaccharide chain (O-PS or
O-antigen). The O-PS is a homopolymer of N-formyl-perosamine.
Brucella strains carrying complete S-LPS have a smooth (S)
phenotype, so termed after the smooth texture of the colonial
surface, while Brucellae devoid of O-PS have a rough (R) phenotype.
B.abortus, B.melitensis, B.suis, B.neotomae, B.microti, as well as the
recently isolated B.pinnipedialis and B.ceti species, express a smooth
phenotype, while B.abortus RB51, B.melitensis B115, B.ovis and
B.canis are typically rough strains [5,6].
Smooth-to-rough phase variation can spontaneously occur in
Brucella smooth strains as result of environmental factors but the
molecular mechanism responsible for such variation has not yet
been defined [7–9]. Owing to the lack of antigenic O-PS, true R-
mutants neither induce anti O-PS antibodies which could interfere
with a serologic diagnosis of brucellosis, nor react with anti-O-PS
antibodies [5,10]. In addition, these mutants show outer membrane
morphological and physiological changes resulting in the uptake of
crystal violet and the autoagglutination in acriflavine solution [5].
With the exception of B.ovis and B.canis, which are rough but
virulent, R-mutants are less virulent than the wild type.
Because of these features, Brucella R-mutants have been
considered potential brucellosis vaccines [11,12]. The strain
RB51 has replaced the S19 as vaccine for brucellosis in cattle in
many countries [12]. RB51 is a spontaneous R-mutant derived
from the virulent strain B.abortus 2308 after a series of passages in
selective media [10]. It expresses no O-PS on its cell surface, and
therefore induces no diagnostically undesirable antibodies, mainly
directed against this antigen [10,13,14]. Nevertheless, it produces
anti-RB51 antibodies, as detected by specific serologic tests
[13,15]. Genetic analysis showed that RB51 carries the genetic
element IS711, spontaneously inserted into the wboA gene [16].
Complementation of RB51 with wboA, has been shown to increase
O-PS expression without, however, restoring the smooth pheno-
type, suggesting the presence of additional mutations responsible
for its rough morphology [17–20].
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e24073B.melitensis B115 is a natural, stable, rough strain, the phenotype
of which has been evaluated according to classical criteria [5].
Many reports confirmed the lack of surface O-PS. Additional
studies, however, demonstrated the presence of detectable O-
antigen in the cytoplasm [21,22].
The mechanism of LPS synthesis is largely unknown, but
genetic studies indicate that it is similar to that existing in some
gram-negative bacteria. Several genes have been proven to be
involved in the biosynthetic pathways of lipid A, core, and O-PS
[7,11,16,19,23,24]. Most of these genes are clustered in two
genetic regions, wbk and wbo. R-mutants can result from mutations
affecting O-PS precursor synthesis, its polymerization and export,
or from a variety of defects in the inner core polysaccharide
[11,25,26].
In preliminary studies conducted in our laboratory to assess the
potential value of B115 as vaccine, B115 was unable to induce
antibodies to O-PS in mice, even when administered at high
dosages. Nevertheless, it elicited specific anti-B115 antibodies and
was able to confer good protection [27,28]. B.melitensis 18 is a
rough, stable, rifampin-resitant mutant of B.melitensis isolated in
our laboratory by several passages on Brucella agar medium
supplemented with rifampin. B18 showed different antigenic and
immunological properties compared to other strains – despite its
rough morphology, it induced detectable anti-O-PS antibodies in
laboratory animals [29].
In this study, we compared the antigenic and immunologic
characteristics of RB51, B115 and B18. A molecular analysis, for
each strain, of the 21 genes known to be involved in LPS synthesis
was also performed. The genes of the three rough strains under
study were PCR-amplified and sequenced, and the results
compared to a smooth reference strain B.melitensis 16M the
sequences of which had been published in GenBank [30]. This
preliminary study would ultimately allow an in-depth investigation
of potential correlations between immunologic characteristics and
genetic makeup, necessary for the development of novel Brucella
vaccines.
Materials and Methods
Bacterial strains and growth conditions
B.melitensis B115 and B.abortus 99 were provided to us by the
Veterinary Laboratories Agency (VLA) of Weybridge (U.K.), while
the B.abortus RB51 vaccine strain was isolated from the
commercial vaccine ‘‘RB-51 CZV’’, (Cooper-Zeltia Veterinaria,
SA, Spain). B.melitensis B18 was isolated in our laboratory after
several passages on Brucella agar medium supplemented with
rifampin, as previously described [29]. All Brucella strains were
cultured at 37uC for 48 h on Trypticase Soy Agar (TSA, OXOID)
supplemented with 5% sterile horse serum.
Animals
For serological analysis, New Zealand white (NZW) rabbits,
weighting 1.2–1.5 kg, provided by the Harlan Italy (Udine, Italy),
were used. All animal experiments were conducted in ABL3
facilities, in keeping with current European legislation (directive
86/609/EEC).
Ethics statement
Experiments with mice, according to National (D.L. 116/92)
and European (86/609/EEC) regulations, were previously autho-
rized by the National Authority (Decreto 225/2009-B). Bovine
serum samples collected from B.abortus 99-naturally-infected cattle
were provided by the Istituti Zooprofilattici Sperimentali,
responsible for the serological surveillance of herds as prescribed
by the Italian brucellosis eradication plan. For these sera, no
ethical approval was sought, as they were obtained from animals
that contracted the infection naturally.
Antigenic characterization and antibody response
evaluation
The smooth or rough phenotype of Brucella strains was
determined by classical criteria, such as crystal violet staining,
acriflavine agglutination (0.1% w/v) and agglutination with
monospecific Brucella sera (to A and M antigens) [5]. Cell-surface
expression of O-PS was tested by evaluating the ability of each
strain to bind antibodies induced by smooth or rough Brucella
strains, in Complement Fixation Tests (CFTs). Bacterial suspen-
sions were prepared with whole cells of B.abortus 99 smooth strain,
B.melitensis B115, B.abortus RB51 and B.melitensis B18. All bacterial
strains were grown at 37uC on TSA, adjusted to a concentration of
10
9 CFU/ml (OD600=0.170) and then heat-inactivated. Before
their use as antigen in CFT, an equal amount of fetal calf serum
(FCS, GIBCO) was added to RB51 suspensions as previously
described [13,15]. This was done in order to neutralize possible
nonspecific reactions due to the anticomplementary activity
characteristic of rough phenotype brucella strains. B18 required
the same treatment to avoid the anti-complementary activity. In
contrast, B.melitensis B115 was used as is, since it showed no
anticomplementary activity in a previous study [27]. To evaluate
antibody response to Brucella strains, three groups of five NZW
rabbits were inoculated subcutaneously (s.c.) with 10
9 CFU/rabbit
of viable RB51, B18 and B115, respectively. Blood samples were
collected by heart puncture at 7, 15, 30, 60, 90, and 140
postinoculation days (PID). Blood was allowed to clot for 12 hours
at 4uC and then centrifuged. Serum samples were divided into
1 ml aliquots and stored at 220uC until use.
The presence of anti-O-PS antibodies was evaluated by the
CFT and the Rose Bengal Plate Test (RBPT), using B.abortus 99
smooth strain as antigen, according to Alton et al. [5]. To detect
antibodies directed against antigens other than O-PS, the CFT
was performed using B115 as rough antigen, as previously
described [27]. Anti-OPS antibodies were obtained from serum
samples taken from B.abortus 99-naturally-infected cattle, provided
to our laboratory by the Istituti Zooprofilattici Sperimentali.
Antibodies directed against antigens other than O-PS were
obtained from serum samples collected from RB51-vaccinated
cattle, previously provided by Dr. Olsen (United States Depart-
ment of Agriculture Ames, IA, USA) for a collaborative study to
validate a specific serologic test [13]. CFTs were performed in
microtitre U-bottom plates as described elsewhere [13,15,27].
Genetic characterization of Brucella strains: DNA
preparation, PCR assay and sequence analysis
Brucella strains were cultured for 48 h at 37uC on TSA slopes.
The pellet was resuspended in 467 ml TE/sodium buffer (50 mM
Tris, 50 mM EDTA, 100 mM NaCl, pH 8) and digested for 1 hr
at 37uC with 3 ml of 20 mg/ml proteinase K and 30 ml of 10%
SDS. DNA was purified twice with phenol-chloroform using Phase
Lock Gel Heavy tubes (Eppendorf AG, Hamburg, Germany).
Nucleic acids were precipitated using isopropanol/sodium acetate
and the pellet resuspended in 50 ml of nuclease-free water. A total
of 21 genes involved in LPS synthesis (17 located in chromosome I
and 4 in chromosome II) were analyzed for each Brucella strain.
The Brucella genes under study and the primers used for PCR
amplifications, designed using the Primer3 software (http://
frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi), are listed
in Table 1. A PostgreSQL database was previously created to
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assigned an identification code (ID). A convenient web interface
allows internet connection to this database, available to registered
users at https://cosmos.bio.uniroma1.it. PCR amplifications were
carried out using the TripleMaster PCR System and the High
Fidelity Buffer (Eppendorf AG, Hamburg, Germany) following the
suggested protocol for high fidelity PCR. About 100 ng of genomic
DNA were used as template for each reaction. Thirty amplification
cycles were performed, each comprising denaturation at 95uC for
2 min, annealing at 55uC for 1 min, and extension at 72uC for
1 min. Ten ml of each reaction mixture were analyzed by
electrophoresis on a 2% agarose gel stained with ethidium bromide.
Table 1. Primers used for PCR and sequencing analysis of genes, involved in the LPS synthesis, examined in this study.
PCR Primers Sequence (59R39) Specificity (gene) Locus
* Putative role
** Amplicon size (bp)
347 1153 AGTGGACGAAACTTGGGATG wboB BMEI 0997 Mannosyltransferase 1686
1154 ATCTCTGCATTCGTGGGAAG
348 1156 GGGTTATAGCCGATAAACACG wboA BMEI 0998 Glycosyltranferase 1297 (2139 in RB51)
1157 CCCGCGCATTAAGAGTAGAC
349 1159 ATGAGCGGACCATAAAGGTG wa 1326 BMEI 1326 protein of unknown function 2253
1160 GCGCTGATTGAGGAAAAGAC
350 1162 ATGCCTCATCTACGCTCCAT wbkE BMEI 1393 Glycosyltranferase 1287
1163 TGTCGAATTTTTGGTTGTCG
351 1165 CGACAACCAAAAATTCGACA manAOAg BMEI 1394 Perosamine synthesis 1256
1166 GAGGATGATTTCGGACGTGT
352 1168 GACAACCAAAGAGGCAAAGC manBOAg BMEI 1395 Perosamine synthesis 1592
1169 TGCAAAGCTCTCTGAAACGA
353 1171 GCGGATGAATTCAGATCGTT manCOAg BMEI 1396 Perosamine synthesis 1466
1172 GTGCCATCCATCATGTGAAC
354 1174 CCTCCTTGCTATCCGATTGA wbkA BMEI 1404 Glycosyltranferase 1271
1175 ATTTGCAAAATCTGGGCAAC
355 1177 TGTAATGCTCCACGAGCAAG gmd BMEI 1413 Perosamine synthesis 1257
1178 ACCCTGTATCAAGGCATTCG
356 1180 GCTGGAAGCCGAAAATCTCT per BMEI 1414 Perosamine synthesis 1297
1181 CACCAGAAGTGGCGTACCTT
357 1183 AGCGCTTCCACAGGATCTTA wzm BMEI 1415 ABC transporter permease 995
1184 ATGCAGCGTAGTGCAGATGA
358 1186 TGCTTAGGTGTGAGCCTCCT wzt BMEI 1416 ABC transporter permease 915
1187 AGAGGGACCTCACATTCTCG
359 1189 AACTCGGGAATGGGAGCTAT wbkB BMEI 1417 Unknown 934
1190 CAAAACGCGTGTATTTGGTG
360 1192 CGTTACCCAAGTTGGAATGC wbkC BMEI 1418 Formyltranferase 890
1193 CTGCTGGGACCAAAAACCTA
361 1195 GTTAGCGGAGGAATGGACAA wbkF (ex wecA) BMEI 1426 Undecaprenyl-P-a-N-
acetylglucosaminyl
1213
1196 CGCCATGGAAAAGAAGGATA
362 1198 CCACACTCATTCTGCTGCTC wbkD BMEI 1427 Unknown 2042
1199 GGTCTGTTACGGTTGCTGGT
363 1201 CACTTGCTGCCTTGATTGAG pgm BMEI 1886 Phosphoglucomutase 1956
1202 TCACTGCCCTACTGCCCTAC
364 1204 ACAGGAGAATTTTCGGCGTA wa 0053 BMEII 0053 Transport ATPase 976
1205 ATCGCTGTTGCAACCTACCT
366 1210 GGCAGATACAGGTTCGATGG manB-core BMEII 0899 Phosphomannomutase 1577
1211 GGTCTTGCCGATGAGTGTTT
367 1213 TGGAATCTTCGGATGACACA manC-core BMEII 0900 Unknown 1526
1214 TTCGCATTTGGCTGAATATG
368 1216 GATGTGGGACTTCCGTTCTG wa**** BMEII 1134 Amidase (?) 1290
GeneBank AE008917 (chromosome I) and AE008918 (chromosome II);
**Moriyon et al. (2004).
doi:10.1371/journal.pone.0024073.t001
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Montage PCRm96 Micro-well Filter Plate (Millipore, Billerica,
Mass). Bidirectional sequencing was performed using the ampli-
fication primers listed in Table 1. Purified products were
sequenced by Macrogen Inc. (10F World Meridian Center 60-
24 Kumchun-Ku, Kasan-Dong, Seoul, Korea 153-023) using an
ABI3730 XL DNA Analyzer (Applied Biosystems, Renton, USA).
The forward and reverse ABI files were aligned and assembled
into a single consensus sequence using MEGA software version 5
(http://www.megasoftware.net/). All sequences were submitted to
BLAST analysis (http://blast.ncbi.nlm.nih.gov/Blast.cgi/) and
nucleotide and amino acid changes identified through comparison
with the corresponding B.melitensis 16M sequences available in
GenBank (AE008917 for chromosome I and AE008918 for
chromosome II).
Results
Surface antigenicity and antibody response in rabbits
The rough phenotype of RB51, B115 and B18, tested by the
classical methods of crystal violet staining and autoagglutination
reaction with acriflavine, was confirmed after passages in culture
media. No reversion to smooth phenotype occurred after passages
in mice and rabbits (data not shown).
In CFTs performed on whole-cell antigen suspensions of RB51,
B18 and B115, B.abortus 99 smooth strain, tested as control, bound
only anti-O-PS antibodies. RB51 and B115 bound antibodies
induced by the rough strain RB51, and did not react with anti-
OPS antibodies induced by the smooth strain B.abortus 99.
In contrast, the rough strain B18 was able to react with both
kinds of antibodies – anti-O-PS and anti-RB51 - giving the same
titres obtained with homologous antigens used separately.
The antibody response induced by Brucella strains in rabbits was
evaluated by CFTs and RBPT, up to 140 PIDs. As expected,
vaccination with RB51 did not induce antibodies to O-PS. At PID
7, 80% of rabbits had seroconverted to the rough antigen B115,
reaching 100% at PID 15. Specific antibodies were still present in
60% of RB51-inoculated rabbits at PID 140.
Similarly, no antibodies to O-PS were detected in sera from
rabbits inoculated with B115. Antibodies to B115 were detected in
80% of these rabbits at PID 7, and in 100% at PID 15. At PID
140, 80% of rabbits were still seropositive.
In the group vaccinated with B18, 80% of rabbits had reacted
with both antigens by PID 7, giving similar titres. By PID 15, both
kinds of antibodies had appeared in 100% of the animals, that had
remained seropositive until PID 90. At pid 140, however, anti-O-
PS antibodies were detected in 80% of rabbits, while only 40%
had antibodies to B115.
Molecular analysis
The results of the molecular analysis performed on 21 genes
involved in LPS synthesis are presented in Table 2. Consensus
sequences of B115, RB51 and B18 strains were compared to the
available B. melitensis 16M genome (AE008917 for chromosome I
andAE008918forchromosomeII)inordertodetectmutations.The
presenceofeachmutationwasconfirmedafterpassagesinmice,thus
confirming the genetic stability of mutants (data not shown).
Of the 21 genes examined, three showed no nucleotide
mutations compared to the genomic sequences of strain 16M
(manAOAg, wbkB, wbKc) in any of the three strains analyzed. Six
genes presented only silent mutations, with no resulting change to
the amino acid sequence of the corresponding protein (wbkE, gmd,
per, wbkF, wa0053, manBcore). Most genes showed a number of
missense mutations (wboB, wboA, wa-1326, manBOAg, manCOAg, wzt,
wzm, wbkD, pgm, manCcore, and wa****). Two nonsense mutations
were also detected, one already known, that is, the interruption of
the wboA gene by an IS711 element in B. abortus RB51; the other, a
point mutation at position 236 in the wzm gene for the B115 strain,
that changes the amino acid tryptophan (W) into a stop codon in
position 79 of the protein, resulting in a polypeptide chain that
ends prematurely and a truncated protein product.
Discussion
In the present study, we evaluated the antigenic, immunologic
and genetic characteristics of rough strains B.abortus RB51,
B.melitensis B115 and B.melitensis B18. We amplified and sequenced
21 genes involved in LPS synthesis, in order to detect genetic
mutations which could ultimately be correlated with the different
properties of these strains. All sequences were compared with
those of B.melitensis 16M reference strain.
RB51 and B115 are well known strains. Their antigenic, genetic
and immunological characteristics, however, have not been fully
assessed. B18 is a rough, rifampin-resistant mutant of B.melitensis
isolated in our laboratory [29].
In Brucella strains of smooth phenotype, LPS is synthesized as
two separate components, lipid A-core and the O-PS. The O-PS is
a homopolymer of N-formyl-perosamine units [24,31]. Several
genes involved in LPS biosynthesis have been recognized, most of
them clustered in the wbk and wbo genetic regions [11]. The wbo
region encodes two putative glycosyltranferases, wboA and wboB.
The wbk contains genes coding for enzymes necessary for N-
formylperosamine synthesis (gmd, per), its formylation (wbkC) and
polymerization (wbkE, wbkA), for bactoprenol priming (wbkD and
wbkF) and the ABC transporters for the O-PS translocation (wzm,
wzt). It also contains genes involved in the synthesis of mannose
(manAOAg, manBOAg and manCOAg), which probably act coordinately
with gmd and per, and independently with other genes [18,32,33].
Finally, three genes have been shown to be involved in core
synthesis - pgm, manBcore and wa**** [26].
These genetic regions, central for LPS synthesis in smooth
strains, may be expected to be absent or different in rough strains.
And indeed, B.ovis is naturally devoid of the wbo region [34]. The
wbk region, however, is present both in B.ovis and in B.canis, which
are natural rough strains [25]. The disruption of wbkB and
manBOAg does not generate rough mutants [24,26].
Transposon mutagenesis and complementation studies, gener-
ating different rough mutants, confirmed the crucial role of these
genes [24,26].
B.abortus rough strain RB51 has no O-PS exposed on its cell
surface but it is not completely devoid of O-PS: it has been
demonstrated that RB51 produces low levels of M-like O-antigen
[35]. Genetic analysis revealed that RB51 carries an IS711
element spontaneously inserted into the wboA gene, which maps
outside of the main wbk region [16]. The wboA encodes for a
glycosyltranferase that is essential for the polymerization of the O-
antigen [17]: disruption of this gene in B.abortus, B.melitensis and
B.suis resulted in rough mutants that were unable to synthetize the
O-PS [36]. The complementation of RB51 with functional wboA
(RB51WboA) increased O-PS expression, but the resulting low
levels of O-PS were present in the cytoplasm, and not on the
surface [19,20]. It has been suggested that other LPS biosynthetic
genes may have been modified affecting the export of O-PS and S-
LPS to the bacterial surface or the appropriate coupling of the O-
antigen to the core-LPS or both. In mice, the RB51WboA strain
induced detectable antibodies to the O-antigen and showed an
enhanced vaccine efficacy against the B.abortus 2308 virulent
strain, without affecting its attenuation characteristic [19,20].
Characterization of Brucella Rough Strains
PLoS ONE | www.plosone.org 4 October 2011 | Volume 6 | Issue 10 | e24073Table 2. Mutations detected in LPS-synthesis genes of B.melitensis B115, B.abortus RB51 and B.melitensis B18.
PCR Gene D B.melitensis B115 B. abortus RB51 B.melitensis B1 8
nucleotide
position
protein
position T nucleotide position
protein
position T
nucleotide
position
protein
position T
347 wboB (1560 bp) r None T to C (347) L to S (116) M T to C (347) L to S (116) M
T to C (447) G to G (149) S
A to G (690) A to A (230) S
T to C (756) Y to Y (252) S
G to A (971) R to Q (324) M
348 wboA (1233 bp) r None 842 bp insertion(706) frameshift (236) N C to A (943) H to N (315) M
T to G (1086) S to S (362) S
349 wa -1326
(2166 bp)
R None C to T (278) S to L (93) M C to T (278) S to L (93) M
T to G (651) A to A (217) S
A to C (801) Q to H (267) M
350 wbkE (1134 bp) r None C to T (216) L to L (72) S None
351 manAAog
(1164 bp)
r None None None
352 manBOag
(1425 bp)
r None C to T (1141) L to F (381) M G to A (210) A to A (70) S
C to T (1141) L to F (381) M
353 manCOag
(1374 bp)
r A to G (903) R to R (301) S A to G (395) D to G (132) M T to C (397) F to L (133) M
T to C (397) F to L (133) M
C to T (817) L to F (273) M A to G (903) R to R (301) S
A to G (903) R to R (301) S
354 wbkA (1119 bp) r None C to A (1047) N to K (349) M None
T to C (1059) S to S (353) S
355 gmd (1089 bp) R None A to G (519) E to E (173) S None
G to C (975) P to P (325) S
356 per (1143 bp) R C to T (690) Y to Y (230) S T to C (144) S to S (48) S None
357 wzm (798 bp) R G to A (236) W to STOP
(79)
N C to A (360)
T to C (455)
V to V (120)
L to P (152)
S
M
None
358 wzt (759 bp) R None A to C (512) D to A (171) M None
359 wbkB (855 bp) R None None None
360 wbkC (780 bp) R None None None
361 wbkF (1008 bp) R None G to A (48) G to G (16) S None
362 wbkD (1869) r None C to T (263) T to I (88) M A to C (615) P to P (205) S
G to A (1300) V to I (434) M C to T ( 920) T to M (307) M
A to G (1338) K to K (446) S A to G (1338) K to K (446) S
G to A (1675) E to K (559) M G to A (1757) G to D ( 586) M
A to G (1819) K to E (607) M A to G (1819) K to E (607) M
363 pgm (1701 bp) R A to G (752) H to R (251) M A to G (752) H to R (251) M A to G (752) H to R (251) M
C to T (1527) S to S (509) S
364 wa (0053)
(741 bp)
r None T to C (672) S to S (224) S None
366 manBcore
(1434 bp)
R C to T (279) G to G (93) S C to T (279) G to G (93) S C to T (279) G to G (93) S
C to T (1335) R to R (445) S
367 manCcore
(1416 bp)
R None G to C (64) D to H (22) M None
368 wa ****
(1206 bp)
R None T to A (388) S to T (130) M A to C (751) S to R (251) M
A to C (751) S to R (251) M
T to C (758) I to T (253) M C to T (1155) S to S (385) S
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been found to be very stable, even after passages in vivo [5,37].
Based on its rpoB nucleotide sequence, it has been classified as
B.melitensis biotype 1 [38]. Many studies confirmed the absence of
surface O-PS in this strain. Interestingly, however, low-titre anti-
O-PS antibodies have been detected in rabbits immunized with
live or killed B115 [37] and O-PS specific monoclonal antibodies
obtained when mice were immunized with B115 [39,40].
Immunogold labelling using O-PS specific monoclonal antibodies
revealed that the O-PS was present in the cytoplasm and that some
of the expressed O-antigen was lipid-bound and associated with
the cell wall [21,22]. In previous studies conducted in our
laboratory, however, B115 didn’t induce antibodies to O-PS in
mice, even when it was given twice at high dosages, while
detectable anti-B115 antibodies were produced [27,28].
Several hypotheses have been formulated to explain the rough
phenotype of B.melitensis B115 despite its O-chain expression [39].
Two genes, wzm and wzt, have been identified as encoding
proteins with high similarity to several two-component ABC
transporters. Their involvement in O-PS translocation across the
inner membrane was confirmed by gene replacement. The
deletion of these two genes resulted in an inability to express
LPS. B.melitensis wzm/wzt mutants, generated in B.melitensis 16M by
allelic replacement strategy, resulted in colonies of rough
phenotype with intracellular accumulation of free O-PS, not
bound to the lipid A-core molecule [24,41].
When functional wzm and wzt genes cloned into plasmids were
supplied, the wild-type phenotype was restored.
In contrast, in B115, the same complementation failed to restore
the smooth phenotype. The possibility has, thus, been raised, that
additional mutations may be present, affecting the LPS O-side-
chain transport or ligation to the lipid A- core molecule [24].
In this study, we tested the surface O-PS expression of RB51, B115
and B18 by evaluating their ability to bind antibodies directed against
O-PS or against antigens other than O-PS. This was done by CFTs,
using whole-cell suspensions of RB51, B115 and B18 as antigens.
CFT results confirmed that RB51 whole cells bind homologous
antibodies and fail to react with antibodies directed to O-PS.
Similarly, whole cells of B115 did not bind anti-O-PS antibodies,
as previously indicated [42], but did react with antibodies induced
by the rough strain RB51. Interestingly, however, B18 was able to
bind both kinds of antibodies.
Moreover, like RB51, the strain B18 needed to be previously
incubated with FCS to neutralize anticomplementary activity
causing non specific reactions in CFTs. In contrast, B115 was
naturally devoid of anticomplementary activity and did not require
the addition of FCS.
Our data thus confirm that, despite the rough phenotype in
common, the three strains under study - RB51, B115 and B18 -
present differences in their surface antigenicity, including the
expression of O-PS on the cell-surface of the B18 strain.
The antibody response induced by RB51, B18 and B115 was
tested in three groups of rabbits, respectively. Antibodies to O-PS
were detected using the B.abortus S99-based CFT [5], while specific
antibodies induced by rough Brucella strains were detected by a
B115-based CFT [43].
The CFT was used as a serological test because of its ability to
detect antibodies induced by rough Brucella strains with satisfactory
sensitivity and specificity, as previously demonstrated [13,27].
The results confirmed that B115 and RB51 fail to elicit anti-O-
PS antibodies, while both induce specific antibodies still detectable
at PID 140 . The lack of anti-O-PS antibodies in B115 and RB51-
inoculated rabbits was confirmed by B.abortus 99-based RBPT.
The production of specific antibodies induced by B115 and RB51
in rabbits was similar to that observed in mice in a previous study
[27].
All B18-inoculated rabbits produced both anti-O-PS antibodies
and specific anti-B18 antibodies, in similar titres. At PID 140, 80%
of sera still contained low levels of antibodies to O-PS, while
specific anti-B18 antibodies were detected only in 40% of rabbits.
This may have been due to a relatively low sensitivity of the B115-
based CFT in detecting anti-B18 antibodies.
Serological results confirmed the absence of surface O-PS in
RB51 and B115 and the presence of the O-PS antigen in B18. We
didn’t investigate the presence of intracellular O-PS in B18. Our
antigenic results, however, suggest that it may be exposed at
surface.
These data also indicate that intracellular O-PS in B115 is
incapable of eliciting detectable O-PS response. This is not
surprising; a similar phenomenon has been reported for the Dpgm
rough mutant, which harbours small amounts of cytoplasmic O-
antigen but fails to induce antibodies to O-PS in mice [4]. The
nature of this lack of response remains to be determined.
The genetic analysis of RB51, B115 and B18, performed by
comparing the sequences of 21 genes involved in LPS-synthesis
with those of the B.melitensis 16M strain, indicated the presence of
some mutations, most of them missense mutations.
The nucleotide and amino acid differences detected in the genes
examined are shown in Table 2. Passages in mice confirmed the
stability of all mutations.
Sequence analysis of B115 genes revealed high homology with
B.melitensis 16M, with few genetic differences detected - six point
mutations, four of the silent type, one missense, and one nonsense.
Silent mutations were present in genes manCOAg, per and manBcore.
A missense mutation was detected in the pgm gene. This mutation
was also present in RB51 and B18. The gene pgm plays a central
role in O-PS biosynthesis since it codes for the enzyme
phosphoglucomutase which is responsible for the interconversion
of glucose-6-phosphate to glucose-1-phosphate, and is thus
essential to the biosynthesis of glucose or galactose in B.abortus [3].
A nonsense mutation was detected in the wzm gene. Since this
gene was found to be responsible for the incorporation of the O-PS
to the periplasmic side of the membrane, such mutation may be
linked to the rough morphology of B115. In addition, this
mutation - detected only in B115 - can therefore be used as a
marker for the molecular identification and differentiation of
B115.
In RB51, beyond the well known insertion in gene wboA [16,17],
we detected several genetic differences between the RB51 strain
and the published B.melitensis 16M genome (Table 2). Silent
mutations were detected in wbkE, gmd, per, wbkF, wa (0053) and
manBcore. Missense mutations were detected in eleven genes: wboB,
D: direction of transcription of the gene; T: type of mutation; M: missense; S: silent; N: nonsense. Mutations identified are referenced to B.melitensis 16M.
(AE 008917 for chromosome I and AE008918 for chromosome II).
doi:10.1371/journal.pone.0024073.t002
Table 2. Cont.
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and wa****. The significance of these mutations and the
correlation with the rough morphology are not easy to interpret,
as not all missense mutations lead to protein changes able to
disrupt normal function.
The mutations detected in genes wzm and wzt could explain the
fact, that while complementation of RB51 with a functional wboA
increases intracellular O-chain expression, it does not restore the
smooth phenotype. As shown, some of the mutations identified in
RB51 were also present in B18.
In B18, missense mutations were detected in eight of the 21
genes sequenced. The genes showing this kind of mutation were
wboB, wboA, wa-1326, manBOAg, manCOAg, wbkD, pgm and wa****
Only one silent mutation was detected, in manBcore, while the
sequences of genes wbkE, manAOAg, wbkA, gmd, per, wzm, wzt, wbkB
and wbkC, wbkF, wa(0053), manCcore were identical to those of the
B.melitensis 16M reference strain.
Interestingly, in strain B18, which seemed to express surface O-
PS, genes wbkA, gmd, per, wzm, wzt, wbkB and wbkC showed no
genetic diversity.
These genes had been identified as involved in the biosynthesis
of the LPS O-side chain [25]. It has later been shown, however,
that they were highly conserved not only in the classical S-type
Brucella species, but also in the rough strains B.ovis and B.canis,
suggesting that other genes should be responsible for the rough
morphology [25].
Our results indicate that the rough strains RB51, B115 and B18,
characterized by different antigenic and immunologic properties,
show differences in genes involved in LPS synthesis. We were able
to identify the specific genes affected by such mutations. These
findings may provide a valuable basis for further investigations
(e.g. complementation studies) to assess the precise role of each
mutation in determining the Brucella phenotype and its character-
istics, essential for the development of attenuated and immuno-
genic vaccines.
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